Stocks · Health care · Surgical & Medical Instruments & Apparatus

enVVeno Medical Corp

NVNO Clue Score20
United States Fiscal year ends December CIK 0001661053 Results filed 29 Apr 2026

What the insiders did Net selling

By person

10 insiders · 53 transactions
4.7×

Robert A. Berman holds only 4.7 times base salary in stock. $2.49M of shares against $525.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Robert A. Berman last reported holding, valued at $11.21, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Biodyne Holding, S.A. entity
Former 10% Owner
—
$1.32M (31)
−$1.32M
1,405,433
$15.75M
−68.4%
Francis Duhay
Director
$348.18K (3)
$8.99K (5) scheduled
+$339.19K
2,351
$26.35K
—
Robert Andrew Berman
Chief Executive Officer
$112.11K (6)
—
+$112.11K
222,236
$2.49M
—
Hamed Alavi
Chief Technology Officer
—
$51.84K (1) scheduled
−$51.84K
0
$0.00
—
Matthew Jenusaitis
Director
$34.35K (2)
—
+$34.35K
16,545
$185.47K
—
Robert Gray
Director
$22.79K (2)
—
+$22.79K
11,155
$125.05K
—
Sanjay Shrivastava
Director
$19.51K (2)
—
+$19.51K
9,288
$104.12K
—
Marc H. Glickman
SVP & Chief Medical Officer
$9.44K (1)
—
+$9.44K
101,600
$1.14M
—
Benedict Broennimann
Chief Medical Officer, OUS
—
—
—
437,778
$4.91M
+0.8%
Craig Glynn
Chief Financial Officer
—
—
—
50,000
$560.50K
—

No percentages here. This company's share count has moved by a factor of 30.8 over the window, from 655,521 to 20,216,176 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.